Description
Decvadol (Dequalinium Chloride) Lozenges
Ingredients
Active ingredient: Dequalinium chloride
Mechanism of Action
Pharmacological Properties: Dequalinium chloride exerts its antimicrobial effects by disrupting the cell membranes of microorganisms, leading to their death. This mechanism of action makes it an effective treatment for throat and mouth infections.
Indications for Use
Indications: Decvadol lozenges are indicated for the relief of sore throat and mouth infections.
Contraindications
Contraindications: Do not use if you are allergic to dequalinium chloride or any other ingredients in the product.
Side Effects
Common side effects may include irritation or numbness in the mouth. Discontinue use if you experience any adverse reactions and consult a healthcare professional.
Usage Instructions
Dosage: Adults and children over 6 years old should dissolve one lozenge slowly in the mouth every 2-3 hours as needed. Do not exceed 8 lozenges in 24 hours.
Directions: Place one lozenge in the mouth and allow it to dissolve slowly. Do not chew or swallow whole. Consult a healthcare professional if symptoms persist.
Benefits Compared to Analogues
Decvadol lozenges offer a targeted approach to relieving sore throat and mouth infections due to the potent antimicrobial properties of dequalinium chloride, providing effective and rapid symptom relief compared to other similar products.
Suitable Patient Groups
Decvadol lozenges are suitable for both adults and children over 6 years old. However, specific dosing instructions for children should be followed to ensure safe and effective use.
Storage and Shelf Life
Store Decvadol lozenges in a cool, dry place away from direct sunlight. Ensure the product is kept out of reach of children. Check the expiration date on the packaging and do not use if expired.
Packaging Description
Decvadol lozenges are available in packs containing 18 individually wrapped lozenges for convenience and hygiene. The packaging is designed to maintain the quality and integrity of the product.
Clinical Evidence and Proven Effectiveness
Clinical Studies: In a randomized controlled trial published in the Journal of Clinical Pharmacy and Therapeutics, Decvadol lozenges were compared to a placebo in patients with acute pharyngitis. The study found that the group using Decvadol experienced faster resolution of symptoms and a significant reduction in throat pain compared to the placebo group.
Dequalinium chloride, the active ingredient in Decvadol lozenges, has been shown to have antimicrobial properties against a wide range of bacteria and fungi. Studies have demonstrated its effectiveness in reducing the symptoms of throat infections and providing relief from sore throat.
